A range of current precision oncology clinical trials are reliant on customized, targeted NGS-panel assays in order to ...

(NYSE:NGS) by taking the forecast future cash flows of the company and discounting them back to today's value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. Before you ...

Targeted sequencing has many applications in cancer biomarker research, carrier screening and inherited disorders, drug development, mitochondrial DNA variant detection, human ID and paternity testing ...